The Role of Inflammatory Pathways in the Development of Rosacea

Rosacea is a prevalent yet poorly understood chronic inflammatory skin condition, characterized by symptoms such as flushing, erythema, papules, and telangiectasia. Although the precise causes of rosacea remain unclear, its pathogenesis involves complex interactions between genetic, environmental,...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamila Sieradocha, Wiktoria Jedlikowska, Natalia Furlepa
Format: Article
Language:English
Published: Kazimierz Wielki University 2024-11-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/56142
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850067033618644992
author Kamila Sieradocha
Wiktoria Jedlikowska
Natalia Furlepa
author_facet Kamila Sieradocha
Wiktoria Jedlikowska
Natalia Furlepa
author_sort Kamila Sieradocha
collection DOAJ
description Rosacea is a prevalent yet poorly understood chronic inflammatory skin condition, characterized by symptoms such as flushing, erythema, papules, and telangiectasia. Although the precise causes of rosacea remain unclear, its pathogenesis involves complex interactions between genetic, environmental, microbial, and immune factors. Recent studies highlight a crucial role for both the innate and adaptive immune systems, implicating Toll-like receptors, neutrophils, macrophages, and cytokines as central to the inflammatory cascade seen in rosacea. Additionally, the overexpression of molecules like cathelicidin and vascular endothelial growth factor (VEGF) contributes to the disease's hallmark features, such as vasodilation and angiogenesis. Trigger factors including UV radiation, dietary components, and microbial influences further exacerbate inflammation, underscoring the multi-factorial nature of the condition. Traditional treatment options, like topical metronidazole, azelaic acid, and oral tetracyclines, have demonstrated efficacy in controlling mild to moderate cases of rosacea. However, more severe cases remain challenging to treat, prompting exploration into novel therapies like IL-17 inhibitors, laser therapy, and probiotics. This review investigates the inflammatory pathways central to rosacea pathogenesis and evaluates emerging therapeutic approaches aimed at addressing the underlying mechanisms of this condition. Understanding these pathways may lead to more effective treatment strategies, improving patient outcomes and quality of life.
format Article
id doaj-art-4685fae47b24412daf0f997fc13b2a4d
institution DOAJ
issn 2391-8306
language English
publishDate 2024-11-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj-art-4685fae47b24412daf0f997fc13b2a4d2025-08-20T02:48:30ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062024-11-017110.12775/JEHS.2024.71.56142The Role of Inflammatory Pathways in the Development of RosaceaKamila Sieradocha0Wiktoria JedlikowskaNatalia FurlepaUniversity Clinical Hospital in Poznan Rosacea is a prevalent yet poorly understood chronic inflammatory skin condition, characterized by symptoms such as flushing, erythema, papules, and telangiectasia. Although the precise causes of rosacea remain unclear, its pathogenesis involves complex interactions between genetic, environmental, microbial, and immune factors. Recent studies highlight a crucial role for both the innate and adaptive immune systems, implicating Toll-like receptors, neutrophils, macrophages, and cytokines as central to the inflammatory cascade seen in rosacea. Additionally, the overexpression of molecules like cathelicidin and vascular endothelial growth factor (VEGF) contributes to the disease's hallmark features, such as vasodilation and angiogenesis. Trigger factors including UV radiation, dietary components, and microbial influences further exacerbate inflammation, underscoring the multi-factorial nature of the condition. Traditional treatment options, like topical metronidazole, azelaic acid, and oral tetracyclines, have demonstrated efficacy in controlling mild to moderate cases of rosacea. However, more severe cases remain challenging to treat, prompting exploration into novel therapies like IL-17 inhibitors, laser therapy, and probiotics. This review investigates the inflammatory pathways central to rosacea pathogenesis and evaluates emerging therapeutic approaches aimed at addressing the underlying mechanisms of this condition. Understanding these pathways may lead to more effective treatment strategies, improving patient outcomes and quality of life. https://apcz.umk.pl/JEHS/article/view/56142rosacea, inflammatory pathways, immune response, toll-like receptors (TLRs), UV radiation
spellingShingle Kamila Sieradocha
Wiktoria Jedlikowska
Natalia Furlepa
The Role of Inflammatory Pathways in the Development of Rosacea
Journal of Education, Health and Sport
rosacea, inflammatory pathways, immune response, toll-like receptors (TLRs), UV radiation
title The Role of Inflammatory Pathways in the Development of Rosacea
title_full The Role of Inflammatory Pathways in the Development of Rosacea
title_fullStr The Role of Inflammatory Pathways in the Development of Rosacea
title_full_unstemmed The Role of Inflammatory Pathways in the Development of Rosacea
title_short The Role of Inflammatory Pathways in the Development of Rosacea
title_sort role of inflammatory pathways in the development of rosacea
topic rosacea, inflammatory pathways, immune response, toll-like receptors (TLRs), UV radiation
url https://apcz.umk.pl/JEHS/article/view/56142
work_keys_str_mv AT kamilasieradocha theroleofinflammatorypathwaysinthedevelopmentofrosacea
AT wiktoriajedlikowska theroleofinflammatorypathwaysinthedevelopmentofrosacea
AT nataliafurlepa theroleofinflammatorypathwaysinthedevelopmentofrosacea
AT kamilasieradocha roleofinflammatorypathwaysinthedevelopmentofrosacea
AT wiktoriajedlikowska roleofinflammatorypathwaysinthedevelopmentofrosacea
AT nataliafurlepa roleofinflammatorypathwaysinthedevelopmentofrosacea